PlainRecalls
FDA Drug Low Class III Terminated

Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.

Reported: September 4, 2019 Initiated: August 6, 2019 #D-1841-2019

Product Description

Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.

Details

Recalling Firm
Akorn, Inc.
Units Affected
8187 vials
Distribution
Nationwide in the U.S.
Location
Lake Forest, IL

Frequently Asked Questions

What product was recalled?
Eptifibatide Injection, a) 20 mg/10 mL (2 mg/mL),10 mL Single Use Vial, NDC 17478-902-10, b) 200 mg/100 mL (2 mg/mL), 100 mL Single-use Vial, NDC 17478-902-90, For Intravenous Use Only, Rx Only, Manufactured by: Akorn Inc., Lake Forest, IL 60045.. Recalled by Akorn, Inc.. Units affected: 8187 vials.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 4, 2019. Severity: Low. Recall number: D-1841-2019.